NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis

Trends in Cardiovascular Medicine

Volumn 28, Issue 7, 2018, Pages 429-434

  Fuentes, Eduardo ^a   Gibbins, Jonathan M ^b   Holbrook, Lisa M ^b   Palomo, Iván ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Antiplatelet; NADPH oxidase; NOX2; Oxidative stress; Platelet

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CYBB PROTEIN, HUMAN; ENZYME INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANTICOAGULANT THERAPY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD CLOTTING; DRUG EFFECT; ENZYMOLOGY; THROMBOCYTE;

ANIMALS; ANTIOXIDANTS; BLOOD COAGULATION; BLOOD PLATELETS; ENZYME INHIBITORS; HUMANS; NADPH OXIDASE 2; OXIDATIVE STRESS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 85045475584     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2018.03.001     Document Type: Review

References (69)

1. Chatterjee, M., Rath, D., Schlotterbeck, J., Rheinlaender, J., Walker-Allgaier, B., Alnaggar, N., et al. Regulation of oxidized platelet lipidome: implications for coronary artery disease. Eur Heart J.(April), 2017.
2. Sugamura, K., Keaney, J.F. Jr., Reactive oxygen species in cardiovascular disease. Free Radical Biol Med 51:September (5) (2011), 978–992.
3. Morel, A., Bijak, M., Miller, E., Rywaniak, J., Miller, S., Saluk, J., Relationship between the increased haemostatic properties of blood platelets and oxidative stress level in multiple sclerosis patients with the secondary progressive stage. Oxid Med Cell Longevity, 2015, 2015, 240918.
4. Pignatelli, P., Pulcinelli, F.M., Lenti, L., Gazzaniga, P.P., Violi, F., Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 91:January (2) (1998), 484–490.
5. Caccese, D., Pratico, D., Ghiselli, A., Natoli, S., Pignatelli, P., Sanguigni, V., et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation—role of arachidonic acid metabolism. Thromb Haemostasis 83:March (3) (2000), 485–490.
6. Wachowicz, B., Olas, B., Zbikowska, H.M., Buczynski, A., Generation of reactive oxygen species in blood platelets. Platelets 13:May (3) (2002), 175–182.
7. Zhang, P., Du, J., Zhao, L., Wang, X., Zhang, Y., Yan, R., et al. The role of intraplatelet reactive oxygen species in the regulation of platelet glycoprotein Ibalpha ectodomain shedding. Thromb Res 132:6 (2013), 696–701.
8. Sill, J.C., Proper, J.A., Johnson, M.E., Uhl, C.B., Katusic, Z.S., Reactive oxygen species and human platelet GP IIb/IIIa receptor activation. Platelets 18:December (8) (2007), 613–619.
9. Brandes, R.P., Weissmann, N., Schroder, K., Nox family NADPH oxidases: molecular mechanisms of activation. Free Radical Biol Med 76:November (2014), 208–226.
10. Walsh, T.G., Berndt, M.C., Carrim, N., Cowman, J., Kenny, D., Metharom, P., The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation. Redox Biol 2 (2014), 178–186.
11. Bye, A.P., Unsworth, A.J., Gibbins, J.M., Platelet signaling: a complex interplay between inhibitory and activatory networks. J Thromb Haemostasis 14:May (5) (2016), 918–930.
12. Unsworth, A.J., Bye, A.P., Tannetta, D.S., Desborough, M.J.R., Kriek, N., Sage, T., et al. Farnesoid X receptor and liver X receptor ligands initiate formation of coated platelets. Arterioscler Thromb Vasc Biol 37:August (8) (2017), 1482–1493.
13. Jones, C.I., Tucker, K.L., Sasikumar, P., Sage, T., Kaiser, W.J., Moore, C., et al. Integrin-linked kinase regulates the rate of platelet activation and is essential for the formation of stable thrombi. J Thromb Haemostasis 12:August (8) (2014), 1342–1352.
14. Jang, J.Y., Wang, S.B., Min, J.H., Chae, Y.H., Baek, J.Y., Yu, D.Y., et al. Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function. J Biol Chem 290:May (18) (2015), 11432–11442.
15. Pastori, D., Pignatelli, P., Carnevale, R., Violi, F., Nox-2 up-regulation and platelet activation: novel insights. Prostaglandins Other Lipid Mediat 120:July (2015), 50–55.
16. Dayal, S., Wilson, K.M., Motto, D.G., Miller, F.J. Jr., Chauhan, A.K., Lentz, S.R., Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 127:March (12) (2013), 1308–1316.
17. Wang, Z., Cai, F., Chen, X., Luo, M., Hu, L., Lu, Y., The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis. PLoS One, 8(9), 2013, e75044.
18. Iuliano, L., Colavita, A.R., Leo, R., Pratico, D., Violi, F., Oxygen free radicals and platelet activation. Free Radical Biol Med 22:6 (1997), 999–1006.
19. Stepniewska, J., Dolegowska, B., Cecerska-Heryc, E., Golembiewska, E., Malinowska-Jedraszczyk, A., Marchelek-Mysliwiec, M., et al. The activity of antioxidant enzymes in blood platelets in different types of renal replacement therapy: a cross-sectional study. Int Urol Nephrol 48:April (4) (2016), 593–599.
20. Gambaryan, S., Kobsar, A., Hartmann, S., Birschmann, I., Kuhlencordt, P.J., Muller-Esterl, W., et al. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemostasis 6:August (8) (2008), 1376–1384.
21. Seno, T., Inoue, N., Gao, D., Okuda, M., Sumi, Y., Matsui, K., et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 103:September (5) (2001), 399–409.
22. Delaney, M.K., Kim, K., Estevez, B., Xu, Z., Stojanovic-Terpo, A., Shen, B., et al. Differential roles of the NADPH-Oxidase 1 and 2 in platelet activation and thrombosis. Arterioscler Thromb Vasc Biol 36:May (5) (2016 May), 846–854.
23. Iuliano, L., Pratico, D., Ghiselli, A., Bonavita, M.S., Violi, F., Superoxide dismutase triggers activation of “primed” platelets. Arch Biochem Biophys 289:August (1) (1991), 180–183.
24. Krotz, F., Sohn, H.Y., Gloe, T., Zahler, S., Riexinger, T., Schiele, T.M., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100:August (3) (2002), 917–924.
25. Begonja, A.J., Gambaryan, S., Geiger, J., Aktas, B., Pozgajova, M., Nieswandt, B., et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 106:October (8) (2005), 2757–2760.
26. Begonja, A.J., Teichmann, L., Geiger, J., Gambaryan, S., Walter, U., Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS. Blood Cells Mol Dis 36:March–April (2) (2006), 166–170.
27. Liu, Y., Davidson, B.P., Yue, Q., Belcik, T., Xie, A., Inaba, Y., et al. Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging 6:January (1) (2013), 74–82.
28. Sirker, A., Zhang, M., Shah, A.M., NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106:September (5) (2011), 735–747.
29. Cangemi, R., Celestini, A., Calvieri, C., Carnevale, R., Pastori, D., Nocella, C., et al. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 98:July (14) (2012), 1063–1066.
30. Violi, F., Carnevale, R., Calvieri, C., Nocella, C., Falcone, M., Farcomeni, A., et al. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia. Thorax 70:October (10) (2015), 961–966.
31. Carbone, F., Teixeira, P.C., Braunersreuther, V., Mach, F., Vuilleumier, N., Montecucco, F., Pathophysiology and treatments of oxidative injury in ischemic stroke: focus on the phagocytic NADPH oxidase 2. Antioxid Redox Signal 23:August (5) (2015), 460–489.
32. Loffredo, L., Carnevale, R., Cangemi, R., Angelico, F., Augelletti, T., Di Santo, S., et al. NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. Int J Cardiol 165:April (1) (2013), 184–192.
33. Kim, K., Li, J., Tseng, A., Andrews, R.K., Cho, J., NOX2 is critical for heterotypic neutrophil-platelet interactions during vascular inflammation. Blood 126:October (16) (2015), 1952–1964.
34. Cangemi, R., Celestini, A., Del Ben, M., Pignatelli, P., Carnevale, R., Proietti, M., et al. Role of platelets in NOX2 activation mediated by TNFalpha in heart failure. Intern Emerg Med 9:March (2) (2014), 179–185.
35. Chlopicki, S., Olszanecki, R., Janiszewski, M., Laurindo, F.R., Panz, T., Miedzobrodzki, J., Functional role of NADPH oxidase in activation of platelets. Antioxid Redox Signal 6:August (4) (2004), 691–698.
36. Pignatelli, P., Sanguigni, V., Lenti, L., Ferro, D., Finocchi, A., Rossi, P., et al. gp91phox-dependent expression of platelet CD40 ligand. Circulation 110:September (10) (2004), 1326–1329.
37. Violi, F., Pignatelli, P., Platelet NOX, a novel target for anti-thrombotic treatment. Thromb Haemostasis 111:May (5) (2014), 817–823.
38. Martino, F., Loffredo, L., Carnevale, R., Sanguigni, V., Martino, E., Catasca, E., et al. Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase. Pediatrics 122:September (3) (2008), e648–e655.
39. Pignatelli, P., Carnevale, R., Di Santo, S., Bartimoccia, S., Sanguigni, V., Lenti, L., et al. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol 31:February (2) (2011), 423–434.
40. Akbar, H., Duan, X., Saleem, S., Davis, A.K., Zheng, Y., RhoA and Rac1 GTPases fifferentially regulate agonist-receptor mediated reactive oxygen species generation in platelets. PLoS One, 11(9), 2016, e0163227.
41. Dutting, S., Heidenreich, J., Cherpokova, D., Amin, E., Zhang, S.C., Ahmadian, M.R., et al. Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets. J Thromb Haemostasis 13:May (5) (2015), 827–838.
42. Lievens, D., Zernecke, A., Seijkens, T., Soehnlein, O., Beckers, L., Munnix, I.C., et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116:November (20) (2010), 4317–4327.
43. Andre, P., Nannizzi-Alaimo, L., Prasad, S.K., Phillips, D.R., Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:August (8) (2002), 896–899.
44. Chakrabarti, S., Varghese, S., Vitseva, O., Tanriverdi, K., Freedman, J.E., CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 25:November (11) (2005), 2428–2434.
45. Carnevale, R., Loffredo, L., Sanguigni, V., Plebani, A., Rossi, P., Pignata, C., et al. Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous disease. J Am Heart Assoc, 3(June (3)), 2014, e000920.
46. Nieswandt, B., Watson, S.P., Platelet-collagen interaction: is GPVI the central receptor?. Blood 102:July (2) (2003), 449–461.
47. Arthur, J.F., Qiao, J., Shen, Y., Davis, A.K., Dunne, E., Berndt, M.C., et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J Thromb Haemostasis 10:June (6) (2012), 1133–1141.
48. Colas, R., Sassolas, A., Guichardant, M., Cugnet-Anceau, C., Moret, M., Moulin, P., et al. LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia 54:November (11) (2011), 2931–2940.
49. Davi, G., Guagnano, M.T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288:October (16) (2002 2), 2008–2014.
50. Vazzana, N., Ganci, A., Cefalu, A.B., Lattanzio, S., Noto, D., Santoro, N., et al. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. J Am Heart Assoc, 2(April (2)), 2013, e000063.
51. Magwenzi, S., Woodward, C., Wraith, K.S., Aburima, A., Raslan, Z., Jones, H., et al. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood 125:April (17) (2015), 2693–2703.
52. Wraith, K.S., Magwenzi, S., Aburima, A., Wen, Y., Leake, D., Naseem, K.M., Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways. Blood 122:July (4) (2013), 580–589.
53. Korporaal, S.J., Van Eck M, A.J., Ijsseldijk, M., Out, R., Lisman, T., et al. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol 27:November (11) (2007), 2476–2483.
54. Podrez, E.A., Byzova, T.V., Febbraio, M., Salomon, R.G., Ma, Y., Valiyaveettil, M., et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13:September (9) (2007), 1086–1095.
55. Carnevale, R., Bartimoccia, S., Nocella, C., Di Santo, S., Loffredo, L., Illuminati, G., et al. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis 237:November (1) (2014), 108–116.
56. Basili, S., Pignatelli, P., Tanzilli, G., Mangieri, E., Carnevale, R., Nocella, C., et al. Anoxia-reoxygenation enhances platelet thromboxane A2 production via reactive oxygen species-generated NOX2: effect in patients undergoing elective percutaneous coronary intervention. Arterioscler Thromb Vasc Biol 31:August (8) (2011), 1766–1771.
57. Davi, G., Chiarelli, F., Santilli, F., Pomilio, M., Vigneri, S., Falco, A., et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation 107:July (25) (2003), 3199–3203.
58. Carnevale, R., Iuliano, L., Nocella, C., Bartimoccia, S., Trape, S., Russo, R., et al. Relationship between platelet and urinary 8-Iso-PGF2alpha levels in subjects with different degrees of NOX2 regulation. J Am Heart Assoc, 2(June (3)), 2013, e000198.
59. Violi, F., Carnevale, R., Loffredo, L., Pignatelli, P., Gallin, J.I., NADPH oxidase-2 and atherothrombosis: insight from chronic granulomatous disease. Arterioscler Thromb Vasc Biol 37:February (2) (2017), 218–225.
60. Ito, D., Murata, M., Watanabe, K., Yoshida, T., Saito, I., Tanahashi, N., et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31:April (4) (2000), 936–939.
61. Vitseva, O., Flockhart, D.A., Jin, Y., Varghese, S., Freedman, J.E., The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates. J Pharmacol Exp Ther 312:March (3) (2005), 1144–1150.
62. Stef, G., Csiszar, A., Ziangmin, Z., Ferdinandy, P., Ungvari, Z., Veress, G., Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance. Pharmacol Rep 59:July–August (4) (2007), 428–436.
63. Lassegue, B., San Martin, A., Griendling, K.K., Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:May (10) (2012), 1364–1390.
64. Bosco, E.E., Kumar, S., Marchioni, F., Biesiada, J., Kordos, M., Szczur, K., et al. Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. Chem Biol 19:February (2) (2012), 228–242.
65. Jaquet, V., Marcoux, J., Forest, E., Leidal, K.G., McCormick, S., Westermaier, Y., et al. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. Br J Pharmacol 164:September (2b) (2011), 507–520.
66. Smith, S.M., Min, J., Ganesh, T., Diebold, B., Kawahara, T., Zhu, Y., et al. Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. Chem Biol 19:June (6) (2012), 752–763.
67. Altenhofer, S., Radermacher, K.A., Kleikers, P.W., Wingler, K., Schmidt, H.H., Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 23:August (5) (2015), 406–427.
68. Dwivedi, S., Pandey, D., Khandoga, A.L., Brandl, R., Siess, W., Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque. J Transl Med, 8(December), 2010, 128.
69. Akbar, H., Kim, J., Funk, K., Cancelas, J.A., Shang, X., Chen, L., et al. Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation. J Thromb Haemostasis 5:August (8) (2007), 1747–1755.